医疗保健分销市场- 按类型（药品[OTC、仿製药、品牌药]、生物製药[疫苗、单克隆抗体] 和医疗器械分销服务）、最终用途（医院、零售药房） - 全球预测(2024 - 2032 )

Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年06月04日 | 出版商:

Global Market Insights Inc. | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在仓库管理系统 (WMS) 创新和对病人安全的高度关注的推动下，全球医疗保健分销市场在 2024 年至 2032 年间将呈现 7.1% 的复合年增长率。先进的 WMS 技术可提高效率、准确性和法规遵循性，确保药品的安全处理和分配。随着病患安全变得越来越重要，对可靠、可追溯的分配系统的需求不断增加，从而增强了供应链的信任和可靠性。这些创新和安全措施正在推动市场扩张，满足医疗保健产业不断变化的需求，并增强整体分销实践。

例如，2023 年 10 月，Tecsys 推出了用于医疗保健分销的精英仓库管理系统 (WMS)，旨在帮助公司遵守《药品供应链安全法》(DSCSA) 法规。此类创新解决方案的推出反映了该行业对严格监管要求的回应以及对稳健、合规分销实践、推动市场成长和技术创新的需求。

医疗保健分销行业根据类型、最终用途和地区进行划分。

由于对复杂和专业疗法的需求不断增长，到 2032 年，生物製药产品分销服务领域将大幅成长。生物製品和个人化医疗的兴起需要先进的配送解决方案，以确保安全且有效率地处理温度敏感产品。该细分市场受益于严格的监管要求以及精确物流以保持产品功效的需求。对冷链基础设施和专业分销网络的投资增加进一步支撑了生物製药分销服务在市场上的主导地位。

到 2032 年，由于这些药房在医疗机构内管理和配药方面发挥的关键作用，医院药房部门将获得显着增长。随着医院规模的扩大和医疗保健服务的增加，这些设施内对高效、可靠的药品配送的需求不断增加。医院药局需要专门的配送服务来处理各种药物，包括复杂且高成本的治疗药物。它们在患者护理中的核心作用以及精确库存管理的需求推动了它们在市场中的主导地位。

由于其完善的医疗保健基础设施和先进的分销网络，欧洲医疗保健分销市场将在 2032 年之前保持适度的复合年增长率。该地区对监管合规、品质标准和高效供应链的高度重视支撑了其主导地位。此外，欧洲人口老化和对先进医疗产品不断增长的需求推动了对强大分销系统的需求。分销实践中技术与创新的整合进一步增强了欧洲的市场地位，使其成为全球医疗保健分销产业前景的重要贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病发生率高、经济负担大
  - 有利的研发投资前景和随后药物上市的增加
  - 追踪解决方案的成长
  - 越来越多采用仿製药
- 产业陷阱与挑战
  - 营运成本高
  - 严格的法规遵循和变化
成长潜力分析
报销场景
监管环境
- 我们
- 欧洲
- 亚太地区
技术景观
- 核心技术
- 邻近技术
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
医药产品分销服务
- 非处方药/维生素
- 仿製药
- 品牌/创新药
生物医药产品经销服务
- 单株抗体
- 疫苗
- 重组蛋白
- 血液和血液製品
- 其他产品
医疗器材分销服务

第 6 章：市场估计与预测：按最终用途分类，2021 - 2032 年

主要趋势
医院药房
零售药局
其他最终用户

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Alliance Healthcare
AmerisourceBergen Corporation
Anda, Inc.
Cardinal Health, Inc.
Celesio AG
CuraScript SD
Henry Schein, Inc.
McKesson Corporation
Medline Industries, Inc.
Morris & Dickson Co., LLC
Owens & Minor, Inc.
Patterson Companies, Inc.
Pheonix Group
Sinopharm Group
Suzuken Co., Ltd.

简介目录

Product Code: 9732

Global Healthcare Distribution Market will demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure handling and distribution of pharmaceuticals. As patient safety becomes increasingly critical, the demand for reliable, traceable distribution systems rises, fostering trust and reliability in the supply chain. These innovations and safety measures are propelling market expansion, meeting the evolving needs of the healthcare industry, and enhancing overall distribution practices.

For instance, in October 2023, Tecsys introduced its Elite Warehouse Management System (WMS) for Healthcare Distribution, designed to help companies comply with the Drug Supply Chain Security Act (DSCSA) regulations. The introduction of such innovative solutions reflects the industry's response to stringent regulatory requirements and the need for robust, compliant distribution practices, driving market growth and technological innovation.

The healthcare distribution industry is divided based on type, end-use, and region.

The biopharmaceutical product distribution services segment will see a considerable surge by 2032, attributed to the growing demand for complex and specialized therapies. The rise in biologics and personalized medicine requires advanced distribution solutions to ensure the safe and efficient handling of temperature-sensitive products. This segment benefits from stringent regulatory requirements and the need for precise logistics to maintain product efficacy. Increased investment in cold chain infrastructure and specialized distribution networks further supports the dominance of biopharmaceutical distribution services in the market.

The hospital pharmacies segment will garner notable gains by 2032, driven by the critical role these pharmacies play in managing and dispensing medications within healthcare settings. As hospitals expand and healthcare services increase, the demand for efficient, reliable pharmaceutical distribution within these facilities rises. Hospital pharmacies require specialized distribution services to handle a wide range of drugs, including complex and high-cost treatments. Their central role in patient care and the need for precise inventory management drive their dominant position in the market.

Europe healthcare distribution market will secure a moderate CAGR through 2032, owing to its well-established healthcare infrastructure and advanced distribution networks. The region's strong emphasis on regulatory compliance, quality standards, and efficient supply chains supports its dominance. Additionally, Europe's aging population and growing demand for advanced medical products drive the need for robust distribution systems. The integration of technology and innovation in distribution practices further enhances Europe's market position, making it a vital contributor to the global healthcare distribution industry outlook.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 High incidence and large economic burden of chronic diseases
  - 3.2.1.2 Favorable R&D investment scenario and subsequent increase in drug launches
  - 3.2.1.3 Growth of track and trace solutions
  - 3.2.1.4 Growing adoption of generic drugs
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High operational costs
  - 3.2.2.2 Stringent regulatory compliance and changes
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
- 3.5.3 Asia Pacific
3.6 Technological landscape
- 3.6.1 Core technologies
- 3.6.2 Adjacent technologies
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Pharmaceutical product distribution services
- 5.2.1 OTC drugs/vitamins
- 5.2.2 Generic drugs
- 5.2.3 Brand-name/innovator drugs
5.3 Biopharmaceutical product distribution services
- 5.3.1 Monoclonal antibodies
- 5.3.2 Vaccines
- 5.3.3 Recombinant proteins
- 5.3.4 Blood and blood products
- 5.3.5 Other products
5.4 Medical device distribution services

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa